More Losartan Lots Recalled

Another company has recalled another 19 lots of losartan tablets. Vivimed Life Sciences produced the medication and Heritage Pharmaceuticals distributed them. Investigators during routine testing discovered high levels of the carcinogen, NMBA. , have been recalled for exceeding the FDA allowable amount of NMBA.

About NMBA

NMBA (N-Nitroso N-Methyl 4-aminobutyric acid) is a chemical compound that studies have linked to cancer. PubChem showed NMBA exposure caused bladder cancer in rats. The levels FDA investigators discovered are less than the doses in the experiment. However, any dose could potentially cause cancer in humans. This is the second cancer threat. Recalls of losartan, valsartan, and irbesartan started in July 2018. Previously, the only carcinogen identified was NDEA.

New Losartan Lots Recalled

Vivimed Life Sciences removed 19 lots of losartan tablets. This also includes varying strengths of 25mg, 50mg, and 100mg in 90-count or 1,000-count bottles. It is recommended to save any recalled medication for testing. The NMBA recall began in March with Camber Pharmaceuticals and Torrent Pharmaceuticals. Hetero Labs Limited made its medication. Many stores like Walmart, Target, and Kroger distributed these medications.

Lot Numbers

Product Name Lot Number Pack Expiry Date Distributed by
Losartan Potassium Tablets USP, 25 mg CLO17006A 90’s Nov 2019 HERITAGE
Losartan Potassium Tablets USP, 50 mg CLO17007A 1000’s Nov 2019 HERITAGE
Losartan Potassium Tablets USP, 50 mg CLO17008A 1000’s Nov 2019 HERITAGE
Losartan Potassium Tablets USP, 50 mg CLO17009A 1000’s Nov 2019 HERITAGE
Losartan Potassium Tablets USP, 50 mg CLO17009B 90’s Nov 2019 HERITAGE
Losartan Potassium Tablets USP, 50 mg CLO17010A 90’s Nov 2019 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO17012A 90’s Nov 2019 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO17013A 90’s Nov 2019 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO17014A 1000’s Dec 2019 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO17015A 1000’s Jan 2020 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO17016A 1000’s Jan 2020 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO17017A 1000’s Jan 2020 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO18001A 1000’s Jan 2020 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO18002A 90’s Jan 2020 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO18002B 1000’s Jan 2020 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO18020A 90’s Apr 2020 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO18021A 90’s Apr 2020 HERITAGE
Losartan Potassium Tablets USP, 100 mg CLO18022A 90’s Apr 2020 HERITAGE
Losartan Potassium Tablets USP, 50 mg CLO18023A 90’s Apr 2020 HERITAGE

Seek Justice

losartanMany people after taking losartan, valsartan or irbesartan medications are horrified to learn that their medication could have caused their liver cancer. Therefore, it is important to seek justice. These potentially cancer-causing drugs have been on the market for over 5 years. This is unacceptable. You should hold these manufacturers accountable.

We want to help send a message that this is not acceptable. If a dangerous product harmed you, we will be your advocate. Additionally, we have the experience necessary to successfully litigate these cases.

Contact the Michael Brady Lynch Firm today for a free consultation to learn more about seeking justice. A jury may award compensation for any medical expenses associated with this ordeal, as well as for your physical and emotional suffering. There is no obligation.

Leave a Reply

Your email address will not be published. Required fields are marked *

Contact Us Today

Contact our lawyers directly through the email form below.
  • * Denotes a required field
  • This field is for validation purposes and should be left unchanged.